Diagnosis Confirmed, Antibiotics Started
Positive rapid strep test triggers immediate antibiotic prescription today.
- RADT: Confirmatory test (rapid antigen detection)
- Penicillin V: First-line drug (or amoxicillin)
- 10 days: Standard course length (full eradication window)
- ~24 h: Contagious window (after first dose)
Why testing matters
Confirms bacterial cause before starting antibiotics.
Why penicillin works
Targets bacterial cell wall synthesis directly and reliably.
Untreated strep can seed rheumatic fever risk.
Dosing basics
Twice or thrice daily dosing sustains drug levels.
Days 1–3: Symptom Resolution
Fever and throat pain ease quickly as bacterial load plummets.
- 24–48 h: Fever resolution (typical timeline)
- ~70–90%: Load drop by day 3 (with good adherence)
- Fast: Symptom relief (before bacteria are gone)
- ~24 h: Contagiousness ends (post first dose)
Why symptoms fade first
Immune response calms even as bacteria persist.
Load versus feeling
Feeling better does not mean bacteria are gone.
Symptom relief lags behind true bacterial clearance.
Adherence role
Consistent dosing accelerates the early decline curve.
Days 4–9: Feeling Better, Bacteria Remain
Patient feels well; residual bacteria still linger below the surface.
- 5–25%: Residual load, day 6 (depends on adherence)
- Common: Early-stop temptation (top adherence failure point)
- Days 4–9: Doses often missed (peak non-adherence window)
- Rises: Resistance pressure (with incomplete dosing)
Why stopping tempts patients
No symptoms feel like no reason to continue.
Hidden survivors
Low-level bacteria can rebound once pressure lifts.
Stopping early leaves survivors free to regrow.
Resistance selection
Partial courses favor tougher, harder-to-kill bacteria.
Day 10: Full Course vs Early Stop
Side-by-side comparison of finishing versus quitting the antibiotic course.
- <5%: Full-course load, day 10 (near eradication)
- ~20–35%: Stop day 5 residual (meaningful survivors)
- ~40–55%: Stop day 3 residual (high relapse odds)
- 10 days: Recommended minimum (per clinical guidance)
Comparing the two paths
Same start, very different endpoints by day 10.
Why day count matters
Each skipped day leaves more bacteria surviving.
Every day short of ten raises relapse odds.
Adherence compounds it
Missed doses within the course also reduce clearance.
Eradication vs Relapse and Complications
Full courses clear infection reliably; early stops risk relapse and complications.
- ~2–5%: Full-course relapse risk (low residual bacteria)
- Up to 60%+: Early-stop relapse risk (if stopped very early)
- Rheumatic fever: Rare complication (linked to inadequate treatment)
- Finish all doses: Best practice (even after feeling well)
Full-course outcome
Bacteria eradicated, symptoms resolved, relapse rare.
Early-stop outcome
Residual bacteria can rebound within days to weeks.
Finishing every dose is the single best predictor of cure.
Long-term stakes
Repeated partial courses raise community resistance risk.